Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation

R Troisi,L Defreyne,UJ Hesse,M Praet,J Decruyenaere,B De Hemptinnea
DOI: https://doi.org/10.1111/j.1399-0012.1998.tb00975.x
1998-08-01
Clinical Transplantation
Abstract:The results of combined trans‐arterial chemoembolization (TAE) and percutaneous ethanol injection (PEI) followed by liver transplantation for hepatocellular carcinoma (HCC) are described. Fourteen patients (G2) with tumour stages I‐III received a mean of 2 times TAE and 4 times PEI prior to transplantation. Six patients (G1) received no pre‐transplant therapy. Tumor size reduced from 37±16 to 28±16 mm and α‐FP from 339±1057 to 224±711 ng/mL (p = n.s.). On histopathologic examination (G2 vs. G1) a 100% necrosis of the tumour nodules was seen in 80 vs. 0% (p = 0.001); 60‐90% in 3 vs. 1 and 10‐50% in 3 vs. 2. Eighty six percent of nodules in G2 and 36% in GI had a tumour capsule (p = 0.02). After a median follow‐up of 26 months (3–60), 2 patients in G1 developed a recurrence of HCC as compared to 0 in G2 (p = 0.0005). The actuarial patient disease‐free survival after 48 months was 82% in G2 and 65% in Gl. It is concluded that combined treatment with TAE and PEI is inducing necrosis in HCC associated with improved patient disease‐free survival following liver transplantation.
surgery,transplantation
What problem does this paper attempt to address?